Apelin is an endogenous ligand for an APJ that was previously isolated from the stomachs of cows, and the Apelin receptor (APJ) is a member of the family A of G-protein-coupled receptors (GPCRs). The hydrolysis of the 77-amino acid precursor protein apelin results in the production of active peptides with various lengths, including apelin-36, apelin-31, apelin-17, and apelin-13. A number of organs' physiology and pathophysiology depend on the apelin/APJ system, which also controls blood pressure, cardiac contractility, angiogenesis, metabolic balance, and cell growth, apoptosis, and inflammation. Additionally, the central nervous system exhibits widespread apelin/APJ system expression, particularly in neurons and oligodendrocytes. Additionally, APJ contributes to depression and anxiety.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
![[Pyr1]-Apelin-13, Gly(15N) TFA](http://www.invivochem.com/upload/1124/V86534.png)
|
V86534 | [Pyr1]-Apelin-13, Gly(15N) TFA | [Pyr1]-Apelin-13, Gly(15N) TFA is Gly15N-labeled [Pyr1]-Apelin-13. | |
|
V75307 | AM-8123 | 2049973-02-4 | AM-8123 is an orally bioavailable APJ agonist. |
|
V116245 | Apelin agonist 2 | Apelin agonist 2 (compound 35) is an orally effective APLNR agonist. | |
|
V78095 | Apelin-17(human, bovine) TFA | Apelin-17 (human, bovine) TFA is an endogenous orphan G protein-coupled receptor APJ agonist. | |
|
V78096 | Apelin-36(human) TFA | Apelin-36(human) TFA is an endogenous orphan G protein-coupled receptor APJ agonist/activator with EC50 of 20 nM. | |
|
V78097 | Apelin-36(rat, mouse) TFA | Apelin-36(rat, mouse) TFA is an endogenous orphan G protein-coupled receptor APJ agonist. | |
|
V118453 | APJ antagonist-1 | APJ antagonist-1 is an apelin receptor (APJ) antagonist. | |
|
V75315 | APJ receptor agonist 1 | 2287153-38-0 | APJ receptor agonist 1 is a biphenyl acid analogue and a potent APJ receptor (APJ-R) agonist (EC50s of 0.093 and 0.12 nM for human and rat APJ-R, respectively). |
|
V105043 | APJ receptor agonist 10 | 3037373-19-3 | APJ receptor agonist 10 (compound I choline salt) can modulate the activity of APJ receptors and is used in the study of pulmonary hypertension. |
|
V117085 | APJ receptor agonist 10 free base | 2415197-87-2 | APJ receptor agonist 10 free base (compound I) can modulate the activity of APJ receptors and is used in pulmonary hypertension research. |
|
V104766 | APJ receptor agonist 11 | 2135515-67-0 | APJ receptor agonist 11 (Ex 174) is an APJ receptor agonist with IC50 of 0.01-10 nM. |
|
V75308 | APJ receptor agonist 3 | 2759159-56-1 | APJ receptor agonist (activator) 3 is a potent orally bioactive APJ receptor agonist (activator) with EC50 of 0.027 nM. |
|
V75313 | APJ receptor agonist 4 | 2762567-70-2 | APJ receptor agonist 4 is a potent, orally bioactive apelin receptor (APJ) agonist/activator with EC50 and Ki of 0.06 nM and 0.07 nM. |
|
V75312 | APJ receptor agonist 5 | 2135514-20-2 | APJ receptor agonist 5 (compound 3) is a potent orally bioactive apelin receptor (APJ) agonist/activator with EC50 of 0.4 nM. |
|
V75305 | APJ receptor agonist 8 | 2049973-39-7 | APJ receptor agonist 8 (compound 99) is an agonist of APJ receptor. |
|
V75304 | BMS-986224 | 2055200-88-7 | BMS-986224 is a specific and orally bioactive APJ receptor agonist (Kd = 0.3 nM) that displays similar receptor binding and signaling profiles to (Pyr1) apelin-13. |
|
V74628 | ELA-11(human) | 1784687-32-6 | ELA-11 (human), a peptide, is a full agonist of the human apelin receptor with pKi of 7.85. |
|
V74627 | ELA-21 (human) | 2245073-05-4 | ELA-21 (human) is an apelin receptor agonist/activator with pKi of 8.52. |
|
V75310 | ELA-32(human) | 1680205-79-1 | ELA-32 (human) is a potent peptide critical for cardiac development that acts through the G-protein–coupled apelin receptor. |
|
V74625 | Elabela(19-32) | 1886973-05-2 | Elabela(19-32) is the active fragment of ELABELA (ELA) that binds to the apelin receptor (APJ). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
